Hostname: page-component-7479d7b7d-fwgfc Total loading time: 0 Render date: 2024-07-14T10:23:11.188Z Has data issue: false hasContentIssue false
  • English
  • Français

Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data

Published online by Cambridge University Press:  15 May 2009

A. E. Ades
A. E. Ades
Affiliation:
Epidemiology and Biostatistics Unit, Division of Public Health, Institute of Child Health, 30 Guilford Street, London WC1N 1EH
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Accurate incidence information is required to plan and evaluate screening programmes which have been proposed for the detection of primary toxoplasmosis and cytomegalovirus infection in pregnancy. Appropriate statistical methods are described for deriving incidence rates and their confidence intervals from three types of data: change in age-specific seroprevalence, seroconversion, and IgM studies. These methods are applied to seven published studies on toxoplasmosis and cytomegalovirus carried out in the UK. In these publications only one estimate of the infection rate per pregnancy was correctly derived, and none were accompanied by confidence intervals. Using the proposed methods, most estimates of the primary toxoplasmosis rate in these studies were between 2·5 and 5·5 per 1000 pregnancies, compared to the 2 per 1000 usually cited. Most cytomegalovirus incidence estimates were between 4 and 10 per 1000 pregnancies.

Type
Research Article
Information
Epidemiology & Infection , Volume 108 , Issue 2 , April 1992 , pp. 367 - 375
Copyright
Copyright © Cambridge University Press 1992

References

REFERENCES

1.Editorial. Antenatal screening for toxoplasmosis in the UK. Lancet 1990; ii: 346–8.Google Scholar
2.Ho-Yen, DO, Chatterton, JMW, Joss, AWL. Screening for infection in pregnancy. Lancet 1988; ii: 1031.CrossRefGoogle Scholar
3.Ho-Yen, DO. Maternal and fetal screening. Br M J 1990; 300: 1527.CrossRefGoogle Scholar
4.Joss, AWL, Chatterton, JMW, Ho-Yen, DO. Congenital toxoplasmosis: to screen or not to screen? Public Health 1990; 104: 9–20.CrossRefGoogle ScholarPubMed
5.Ho-Yen, DO, Joss, AWL. Toxoplasma and cytomegalovirus infections during pregnancy. Matern Child Health 1988; 13: 225–7.Google Scholar
6.Joynson, DHM, Payne, R. Screening for toxoplasma in pregnancy. Lancet 1988; ii: 795–6.CrossRefGoogle Scholar
7.Ho-Yen, DO. Toxoplasmosis in humans: discussion paper. J R Soc Med 1990; 831: 571.CrossRefGoogle Scholar
8.Ho-Yen, DO, Chatterton, JMW. Congenital toxoplasmosis – why and how to screen. Med Microbiol 1990; 1: 229–35.Google Scholar
9.Preece, P, Pearl, K, Peckham, C. Congenital cytomegalovirus. Arch Dis Childhood 1984; 59: 1120–6.CrossRefGoogle ScholarPubMed
10.Hennekens, CH, Buring, JE. Epidemiology in medicine. Boston/Toronto: Little. Brown. 1989.Google Scholar
11.Anderson, RM, May, RM. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg 1983; 90: 259–325.CrossRefGoogle ScholarPubMed
12.Knox, EG. Strategy for rubella vaccination. Int J Epidemiol 1980; 9: 13–23.CrossRefGoogle ScholarPubMed
13.van Druten, H, van Knapen, F, Reintjes, A. Epidemiologic implications of limited-duration seropositivity after toxoplasma infection. Am J Epidemiol 1990; 132: 169–80.CrossRefGoogle ScholarPubMed
14.Griffiths, DA. A catalytic model of infection for measles. Appl Stat 1974; 23: 330–9.CrossRefGoogle Scholar
15.Grenfell, BT, Anderson, RM. The estimation of age-related rates of infection from case notifications and serological data. J Hyg 1985; 95: 419–36.CrossRefGoogle ScholarPubMed
16.Becker, NG. Analysis of infectious disease data. New York: Chapman and Hall. 1989.Google Scholar
17.Wacholder, S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol 1986; 123: 174–84.CrossRefGoogle ScholarPubMed
18.Ades, AE, Peckham, CS, Dale, GE, Best, JM, Jeansson, S. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health 1989; 43: 53–60.CrossRefGoogle ScholarPubMed
19.Williams, KAB, Scott, JM, MacFarlane, DE, Williamson, JMW, Elias-Jones, TF, Williams, H. Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect 1981; 3: 219–29.CrossRefGoogle ScholarPubMed
20.Joss, AWL, Skinner, LJ, Chatterton, JMW. Simultaneous serological screening for congenital cytomegalovirus and toxoplasma infection. Public Health 1988; 102: 409–17.CrossRefGoogle ScholarPubMed
21.Lentner, C. (ed.) Geigy scientific tables, Vol 2. Geneva: Ciba-Geigy. 1982.Google Scholar
22.Rothman, KJ. Modern epidemiology. Boston/Toronto: Little, Brown, 1986: 358.Google Scholar
23.Griffiths, PD, Baboonian, C. A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaeco 1984; 91: 307–15.CrossRefGoogle ScholarPubMed
24.Ades, AE. Evaluating the sensitivity and predictive value of tests of recent infection: toxoplasmosis in pregnancy. Epidemiol Infect 1991; 107: 527–35.CrossRefGoogle ScholarPubMed
25.Grant, S, Edmond, E, Syme, J. A prospective study of primary cytomegalovirus infection in pregnancy I: Laboratory evidence of congenital infection following maternal primary and reactivated infection. J Infect 1983; 3: 24–31.CrossRefGoogle Scholar
26.Forsgren, N, Gille, E, Ljungstrom, I, Nokes, DJ.Toxoplasma gondii antibodies in pregnant women in Stockholm. 1969, 1979, and 1987. Lancet 1991; 337: 1413–4.CrossRefGoogle ScholarPubMed
27.Walker, J, Nokes, DJ, Jennings, R. Longitudinal study of toxoplasma seroprevalence in South Yorkshire. Epidemiol Infect. In press.Google Scholar
28.Pearl, K, Preece, P, Ades, A, Peckham, C. Neurodevelopmental assessment after congenital cytomegalovirus infection. Arch Dis Child 1986; 61: 323–6.CrossRefGoogle ScholarPubMed
29.Ruoss, CF, Bourne, GL. Toxoplasmosis in pregnancy. J Obstet Gynaecol 1972; 79: 1115–8.Google ScholarPubMed
30.Yarnell, JWG, Milbank, JE. The prevalence of cytomegalovirus antibody in women: an epidemiological study from south Wales. Public Health London 1982; 96: 251–5.CrossRefGoogle ScholarPubMed